Simplex Trading’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-600
| Closed | -$1K | – | 10083 |
|
|
2023
Q2 | $1K | Hold |
600
| – | – | ﹤0.01% | 8765 |
|
|
2023
Q1 | $1K | Sell |
600
-5,600
| -90% | -$21.7K | ﹤0.01% | 8818 |
|
|
2022
Q4 | $22K | Buy |
6,200
+500
| +9% | +$2.17K | ﹤0.01% | 6806 |
|
|
2022
Q3 | $36K | Buy |
+5,700
| New | +$46.3K | ﹤0.01% | 6869 |
|
|
2022
Q1 | – | Sell |
-50
| Closed | -$1K | – | 11594 |
|
|
2021
Q4 | $1K | Sell |
50
-8,530
| -99% | -$345K | ﹤0.01% | 10280 |
|
|
2021
Q3 | $485K | Hold |
8,580
| – | – | ﹤0.01% | 4152 |
|
|
2021
Q2 | $467K | Buy |
8,580
+8,499
| +10,493% | +$503K | ﹤0.01% | 4273 |
|
|
2021
Q1 | $602K | Buy |
81
+77
| +1,925% | +$8K | ﹤0.01% | 3105 |
|
|
2020
Q4 | $44K | Buy |
4
+3
| +300% | +$274 | ﹤0.01% | 6324 |
|
|
2020
Q3 | $6K | Buy |
+1
| New | +$114 | ﹤0.01% | 7064 |
|
|
2019
Q4 | – | Sell |
-1
| Closed | -$13K | – | 8105 |
|
|
2019
Q3 | $13K | Buy |
+1
| New | +$94 | ﹤0.01% | 6111 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6679 |
|
|
2018
Q3 | – | Sell |
-1
| Closed | -$13K | – | 8210 |
|
|
2018
Q2 | $13K | Buy |
+1
| New | +$124 | ﹤0.01% | 6191 |
|
|
2018
Q1 | – | Sell |
-14
| Closed | -$22K | – | 7019 |
|
|
2017
Q4 | $22K | Buy |
+14
| New | +$1.88K | ﹤0.01% | 3224 |
|
Simplex Trading's SYRS Position: Q2 2025 in Review
Simplex Trading sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q2 2025, closing a stake of 4,123 shares.
Simplex Trading first reported a position in SYRS in Q4 2017 and held it in 20 quarters. The position peaked at $255K in Q3 2021. 0 funds tracked by Wall St. Rank hold SYRS as of Q2 2025.
- Simplex Trading reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- Simplex Trading sold 4,123 Syros Pharmaceuticals, Inc. Common Stock shares in Q2 2025.
- Simplex Trading first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 20 quarters.
- Simplex Trading's Syros Pharmaceuticals, Inc. Common Stock position peaked at $255K in Q3 2021.
- 0 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q2 2025.
Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.